Emedgene raises $6 million to scale genomics-based care with AI
Orit Levi2019-02-19T15:20:00+00:00We’re very pleased to announce our recent fundraising round, led by OliveTree Ventures. Although sequencing costs are below $1000, interpretation is still a major bottleneck to widespread adoption of NGS testing and that’s where we’re focusing our efforts. Here’s the full press announcement, detailing the whys and hows: February 19th, 2019, Palo Alto, California -- [...]